Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells

PURPOSE: Tofacitinib is a pan-Janus kinase (JAK) inhibitor that suppresses cytokine signaling and in turn, the cells that participate in inflammatory immunopathogenic processes. We examined the capacity of tofacitinib to inhibit the induction of experimental autoimmune uveitis (EAU) and related immu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Vis
Main Authors: Bing, So Jin, Lyu, Cancan, Xu, Biying, Wandu, Wambui S., Hinshaw, Samuel J., Furumoto, Yasuko, Caspi, Rachel R., Gadina, Massimo, Gery, Igal
Formato: Artigo
Idioma:Inglês
Publicado: Molecular Vision 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531779/
https://ncbi.nlm.nih.gov/pubmed/33088168
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares